Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "advisory"

164 News Found

ABclonal Technology joins YCharOS advisory committee to tackle reproducibility crisis in biomedical research
Biotech | March 21, 2022

ABclonal Technology joins YCharOS advisory committee to tackle reproducibility crisis in biomedical research

Inconsistent antibody performance is a significant challenge for researchers and sits at the heart of the reproducibility crisis observed in biomedical research


U.S. FDA advisory committee recommends J&J booster dose
Biotech | October 18, 2021

U.S. FDA advisory committee recommends J&J booster dose

U.S. FDA to decide whether to authorize a booster dose in the coming days


Peer-led mental health intervention improves transgender well-being: Study
Healthcare | June 04, 2026

Peer-led mental health intervention improves transgender well-being: Study

A total of 300 transgender individuals were screened as part of the study, with 82 identified as high-risk due to symptoms of anxiety, depression, and self-harm or suicidal tendencies


Alembic appoints Ramesh Juneja as Executive Vice President – Human Health for India business
People | June 04, 2026

Alembic appoints Ramesh Juneja as Executive Vice President – Human Health for India business

Juneja brings more than three decades of experience in pharmaceutical sales and marketing


FICCI and Lilly launch Bharat Life Sciences Awards to recognise India’s scientific excellence
R&D | June 03, 2026

FICCI and Lilly launch Bharat Life Sciences Awards to recognise India’s scientific excellence

A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India


Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6
News | June 03, 2026

Omnix Medical doses first patients in phase II trial of antimicrobial lead compound OMN6

First-in-class treatment of life-threatening, drug-resistant Acinetobacter baumannii infections advancing toward Phase II clinical proof-of-concept


FDA delays AstraZeneca decision on camizestrant as regulators seek more data
Drug Approval | May 30, 2026

FDA delays AstraZeneca decision on camizestrant as regulators seek more data

The filing is backed by results from the pivotal SERENA-6 Phase III trial


Ashish Mukkirwar appointed CFO of Jubilant Pharmova
People | May 27, 2026

Ashish Mukkirwar appointed CFO of Jubilant Pharmova

The finance leader and investment banking veteran to steer global financial strategy, investor relations, and growth initiatives


India’s top scientific minds discuss  preparedness against emerging health threats
Policy | May 19, 2026

India’s top scientific minds discuss preparedness against emerging health threats

Discussions during the meeting focused on strengthening India’s preparedness against zoonotic diseases and climate-sensitive health challenges


Experts calls for urgent preventive action as hypertension cases rise
Healthcare | May 18, 2026

Experts calls for urgent preventive action as hypertension cases rise

Union Minister Prataprao Jadhav terms hypertension a “silent killer”; experts push for early screening, lifestyle correction and wellness-focused healthcare